ALS AT HOME is a single-center study of up to 150 participants being done to determine the extent to which frequent sampling can improve the qualities of outcome measures collected at home by study participants.
ALS AT HOME is a single-center study of up to 150 participants being done to determine the extent to which frequent sampling can improve the qualities of outcome measures collected at home by study participants. The objectives of this study are to 1. assess the extent to which frequent sampling can reduce variability for the following outcome measures in ALS patients: ALSFRS-R, quantitative hand grip, pulmonary function, EIM in 4 extremities, and actigraphy and voice/speech tracking; 2. assess the compliance of ALS patients in obtained outcome measures at home over the course of 9 months; 3. directly compare outcome measures collected by patients with measurements obtained at study sites at less frequent intervals by co-enrolling 50 patients participating in the Answer ALS study; and 4. provide information to Answer ALS to more fully characterize patients in that study. The study proposed here will assess the extent to which reducing variability of measurement through frequent sampling can reduce both sample size and duration of clinical trials, provide a first-of-its-kind detailed assessment of disease progression, and evaluate an entirely new paradigm for patient participation in such trials without the need to be geographically yoked to a clinical study center. An important component of this proposal is to jointly recruit 50 patients who also participate in the Answer ALS study that intends to generate 1000 IP cell lines from patients who receive ongoing assessment at 5 clinical sites. The 100 participants that will be co-enrolled in Answer ALS and ALS AT HOME will perform outcome measures at home in addition to having outcome measures performed at clinic sites through Answer ALS participation. Therefore, the investigators will be able to directly assess how the measures obtained by patients at home relate to those obtained by a trained evaluator at a study center using standard metrics. The investigators will also provide all data generated at home to the Answer ALS investigators, further increasing the phenotypic data available for that project.
Study Type
OBSERVATIONAL
Enrollment
144
Respirometer, Handgrip Meter, Skulpt Chisel, ActigraphyMeter
Barrow Neurological Institute
Phoenix, Arizona, United States
Change in Pulmonary Function
Respirometer
Time frame: Daily for the first 3 months; for the subsequent 6 months measures will be obtained twice weekly
Change in Quantitative Hand Grip
Digital Handgrip Meter
Time frame: Daily for the first 3 months; for the subsequent 6 months measures will be obtained twice weekly
Change in Electrical Impedance Myography (EIM) Measurements
Skulpt Chisel
Time frame: Daily for the first 3 months; for the subsequent 6 months measures will be obtained twice weekly
Change in Actigraphy
Activity Band
Time frame: Daily for the first 3 months; for the subsequent 6 months measures will be obtained twice weekly
ALSFRS-R
Questionnaire
Time frame: Weekly up to 9 months
Change in Patient-reported Experience measures (PREMs)
Questionnaire
Time frame: At Week 1, and then at 3, 6, and 9 months
Adverse Events
Questionnaire
Time frame: Monthly up to 9 months
Change in Voice/Speech Tracking
Smartphone application
Time frame: Daily for the first 3 months; for the subsequent 6 months measures will be obtained twice weekly
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.